Updates in the management of severe coagulopathy in trauma patients.
Lynn M, Jeroukhimov I, Klein Y, Martinowitz U
Intensive Care Med 2002;28(Suppl 2):S241-S247.
Review by Aldouri M
Efficacy of recombinant factor VIIa administered by continuous infusion to haemophilia patients with inhibitors.
Mauser-Bunschoten EP, Koopman MMW, Goede-Bolder ADE, et al.
Haemophilia 2002;8(5):649-656.
Review by M. Aldouri
The effect of recombinant factor VIIa on coagulopathic pigs with grade V liver injuries.
Schreiber MA, Holcomb JB, Hedner U, Brundage SI, Macaitis JM, Hoots K
J Trauma 2002;53(2):252-257.
Review by Aldouri M
Massive blood transfusion in the elective surgical setting.
Nice overview, but inconsistency between recommendations in the figures and in the text. – V. Kretschmer
Orthopaedic surgery in haemophilic patients with inhibitors: an overview.
Hvid I, Rodriguez-Merchan EC
Haemophilia 2002;8(3):288-291.
Review by
Continuous infusion of coagulation factor products.
Stachnik JM, Gabay MP
Ann Pharmacother 2002;36(5):882-891.
Review by
Recombinant factor VIIa in the management of surgery and acute bleeding episodes in children with haemophilia and high responding inhibitors.
O’Connell N, McMahon C, Smith J, et al.
Br J Haematol 2002;116(3):632-635.
Review by Aldouri M
Effective hemostasis with rFVIIa treatment in two patients with severe thrombocytopenia and life-threatening hemorrhage.
Gerotziafas GT, Zervas C, Gavrielidis G, et al.
Am J Hematol 2002;69(3):219-222.
Review by M. Aldouri
Potential role for rFVIIa in transfusion medicine.
Hedner U, Erhardtsen E
Transfusion 2002;42(1):114-124.
Review by Aldouri M
Successful use of activated recombinant factor VII to control bleeding abnormalities in a patient with a left ventricular assist device.
Zietkiewicz M, Garlicki M, Domagala J, et al.
J Thorac Cardiovasc Surg 2002;123(2):384-385.
Review by
Mechanism of factor VIIa-dependent coagulation in hemophilia blood.
Butenas S, Brummel KE, Branda RF, Paradis SG, Mann KG
Blood 2002;99(3):923-930.
Review by
Successful outcome of a cirrhotic patient with postoperative haematuria treated with a single high dose of recombinant factor VIIa.
Lucia JF, Aguilar C, Orna E, et al.
Haemophilia 2001;7(6):600-602.
Review by
Use of recombinant factor VII in hepatology.
Romero Castro R, Barroso Relinque N, Caunedo Alvarez AC, et al.
Rev Esp Enferm Dig 2001;93(10):664-668.
Review by
Rationale for the use of high dose rFVIIa in a high-titre inhibitor patient with haemophilia B during major orthopaedic procedures.
Cooper HA, Jones CP, Campion E, Roberts HR, Hedner U
Haemophilia 2001;7(5):517-522.
Review by M. Aldouri
Off-label use of recombinant factor VIIa in patients following bone marrow transplantation.
Blatt J, Gold SH, Wiley JM, Monahan PE, Cooper HC, Harvey D
Bone Marrow Transplant 2001;28(4):405-407.
Review by M. Aldouri
NATA: Network for the Advancement of Patient Blood Management, Haemostasis and Thrombosis
MISSION: Providing a multidisciplinary forum for dialogue between haematologists, transfusion medicine specialists, anaesthesiologists, intensive care and emergency physicians, surgeons, perfusionists, nurses, biomedical scientists and other healthcare professionals.
Sitemap
Contact us
- secretary@nataonline.com
-
NATA
Rue de l’Industrie 24
1040 Bruxelles - VAT: 0781668659